Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 19, 2014
Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution
S Corradini, O M Niemoeller, M Niyazi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2017
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer
K Blackwell, P Gascon, C M Jones, et al.
Oncology Reports
|
April 6, 2006
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer
H J Stemmler, M Schmitt, N Harbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Management of venous port systems in oncology: a review of current evidence
S Vescia, A K Baumgärtner, V R Jacobs, et al.
Breast Cancer Research and Treatment
|
January 9, 2009
Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
Michael Patrick Lux, M Hartmann, C Jackisch, et al.
Oncogene
|
June 29, 2000
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer, D Prechtel, U Knaus, et al.
Cancer Research
|
March 14, 2001
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis
A Krüger, R Soeltl, I Sopov, et al.
The International Journal of Biological Markers
|
April 14, 2000
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer
N Harbeck, U Alt, U Berger, et al.
Anticancer Research
|
August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L
C Thomssen, P Oppelt, F Jänicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
P Hadji, M Blettner, N Harbeck, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 19, 2014
Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution
S Corradini, O M Niemoeller, M Niyazi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2017
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer
K Blackwell, P Gascon, C M Jones, et al.
Oncology Reports
|
April 6, 2006
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer
H J Stemmler, M Schmitt, N Harbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Management of venous port systems in oncology: a review of current evidence
S Vescia, A K Baumgärtner, V R Jacobs, et al.
Breast Cancer Research and Treatment
|
January 9, 2009
Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
Michael Patrick Lux, M Hartmann, C Jackisch, et al.
Oncogene
|
June 29, 2000
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer, D Prechtel, U Knaus, et al.
Cancer Research
|
March 14, 2001
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis
A Krüger, R Soeltl, I Sopov, et al.
The International Journal of Biological Markers
|
April 14, 2000
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer
N Harbeck, U Alt, U Berger, et al.
Anticancer Research
|
August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L
C Thomssen, P Oppelt, F Jänicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
P Hadji, M Blettner, N Harbeck, et al.
Page
of 15